HKU Scholars Hub: Browsing DSpace

Browsing by Author Yang, TS

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 3 of 3

	Title	Author(s)	Issue Date
	Efficacy and safety of every-2-weeks cetuximab combined with FOLFOX or FOLFIRI as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (mCRC): an Asia-Pacific nonrandomized phase II study (APEC) Proceeding/Conference:Journal of Clinical Oncology	Cheng, AL Cornelio, GH Shen, L Price, TJ Yang, TS Chung, IJ Dai, G Lin, JK Sharma, A Yeh, KH Ma, B Zaatar, A Guan, ZZ Masood, N Srimuninnimit, V Yau, TCC Sarholz, B Lim, RSC	2013
	Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study Journal:Clinical Colorectal Cancer	Cheng, AL Cornelio, G Shen, L Price, T Yang, TS Chung, IJ Dai, GH Lin, JK Sharma, A Yeh, KH Ma, B Zaatar, A Guan, Z Masood, N Srimuninnimit, V Yau, TCC Gibbs, P Wang, X Doval, DC Seung-Taek, O Shim, BY Gorospe, C Wang, HM Sirachainan, E Hill, A Suh, KW Beier, F Chatterjee, S Lim, R	2017
	Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma Journal:Hepatology	Cheng, AL Thongprasert, S Lim, HY Sukeepaisarnjaroen, W Yang, TS Wu, CC Chao, Y Chan, SL Kudo, M Ikeda, M Kang, YK Pan, H Numata, K Han, G Balsara, B Zhang, Y Rodriguez, AM Zhang, Y Wang, Y Poon, RTP	2016

Showing results 1 to 3 of 3